TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, in silico filtering identified targeted genes that are involved in cell cycle, growth inhibition, MAPK, ErBb, transforming growth factor beta and p53 signaling pathways that are reported in CML pathogenesis.